This article "2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial" is published in BMJ ADC Fetal and Neonatal.

Author:Paul Clarke

Journal:BMJ ADC Fetal and Neonatal

Year:2023

Podcast type:Expert

The authors are

Paul Clarke, Aung Soe, Amy Nichols, Helen Harizaj, Mark A Webber, Louise Linsell, Jennifer L Bell, Catherine Tremlett, Priyadarsini Muthukumar, Santosh Pattnayak, Christopher Partlett, Andrew King, Ed Juszczak, Paul T Heath

Affiliations:

Neonatal Intensive Care Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK

Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK 

Quadram Institute, Norwich Research Park, Colney Lane, Norwich NR4 7UQ, UK

National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK 

Department of Microbiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK

Centre for Neonatal and Paediatric Infection, Infection and Immunity, Saint George’s University of London, London, UK